SC-24 A Multicenter, Double-Blind, Placebo-Controlled Study of OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid-Tolerant Cancer Patients

  • PASSIK, STEVEN (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date7/19/04 → 2/11/05